Mode
Text Size
Log in / Sign up

Meta-analysis finds small habenula volume reductions in mood disorders do not survive correctionBrain region volume differences in mood disorders may not be significant after statistical correction

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Interpret small habenula volume reductions in mood disorders with caution as they did not survive statistical correction.

This meta-analysis examined habenula volume in individuals with mood disorders (major depressive disorder or bipolar disorder) compared to healthy controls. The analysis pooled data from 15 samples, involving 1,230 participants for left habenula analysis and 1,236 for right habenula analysis. The comparator group consisted of healthy controls, with the primary outcome being habenula volume measured via neuroimaging.

In initial, uncorrected analyses, mood disorder patients showed small but statistically significant reductions in habenula volume compared to controls. For the left habenula, the effect size was d = -0.1367 (p = .0344), and for the right habenula, d = -0.1562 (p = .0409). Absolute volume numbers were not reported. However, when statistical correction for multiple comparisons was applied, these group differences were no longer significant. Furthermore, separate meta-analyses for MDD versus controls and bipolar disorder versus controls also showed no significant differences in habenula volume.

Safety and tolerability data were not reported, as this was an observational neuroimaging study. Key limitations include that the primary findings did not withstand correction for multiple comparisons, and no moderator analyses (such as for age, sex, or medication status) yielded significant results. The funding sources and author conflicts of interest were not reported.

In terms of practice relevance, this analysis provides no robust evidence for consistent habenula volume alterations in mood disorders. The findings highlight the methodological challenges in identifying subtle neuroanatomical biomarkers and underscore that observed associations in initial analyses may not represent reliable effects. This evidence does not support the use of habenula volume as a diagnostic marker in clinical practice.

Scientists conducted a large analysis combining data from 15 previous studies to examine whether a small brain structure called the habenula differs in size between people with mood disorders and those without. The analysis included brain scans from over 1,200 participants, comparing individuals with major depressive disorder or bipolar disorder to healthy controls. The habenula is involved in processing disappointment and stress, making it a region of interest for understanding mood conditions.

When researchers first analyzed the data without statistical adjustments, they found very small volume reductions in both the left and right habenula in people with mood disorders. However, when they applied standard corrections to account for multiple comparisons—a necessary step to avoid false positive findings—these differences were no longer statistically significant. The study also found no clear differences when looking specifically at depression versus bipolar disorder.

This research highlights the importance of careful statistical analysis in brain imaging studies. The initial findings that seemed promising didn't hold up under more rigorous examination, which is common in early-stage brain research. No safety concerns were reported since this was an analysis of existing brain scan data rather than a treatment study.

Readers should understand that this study doesn't provide evidence that the habenula is structurally different in people with mood disorders. The findings suggest we need more research with consistent measurement methods before drawing conclusions about this brain region's role in depression or bipolar disorder. This type of research helps build our basic understanding of the brain but doesn't yet have direct implications for diagnosis or treatment.

What this means for you:
Initial brain volume differences in mood disorders didn't hold up to statistical correction, so more research is needed.

Study Details

Study typeMeta analysis
Sample sizen = 1,230
EvidenceLevel 1
PublishedMar 2026
View Original Abstract ↓
The habenula, a small brain structure involved in processing aversive stimuli, has been strongly implicated in the pathophysiology of mood disorders. While diminutions in hippocampal and medial prefrontal cortex volume have been demonstrated in individuals with a mood disorder, evidence for structural alterations in the habenula remains inconsistent. This set of meta-analyses examines whether individuals with a mood disorder show alterations in habenula volume compared to healthy controls. We conducted six meta-analyses. Two global analyses compared left and right habenula volumes between individuals with a mood disorder (MDD or BD) and healthy controls (HCs), each including 15 samples (left: 1,230 participants; right: 1,236). Four additional analyses compared MDD versus HCs and BD versus HCs for left and right volumes separately. Subgroup and meta-regression analyses tested the habenula segmentation method, medication status, and MRI resolution as moderators. The global meta-analyses pooling MDD and BD data showed small but significant volume reductions in the left ( = -0.1367,  = .0344) and right ( = -0.1562,  = .0409) habenula in mood disorder patients compared to controls. However, these effects did not survive correction for multiple comparisons. After correction, no significant group differences were found in the diagnosis-specific meta-analyses (MDD versus controls; BD versus controls), and no moderator analyses were significant. Current evidence points toward small habenula volume reductions in mood disorders, though findings did not withstand correction for multiple comparisons. Further high-resolution neuroimaging studies are needed to clarify habenula volume alterations in mood disorders.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.